Abstracts: Accepted Symposium
- A weight management program for the severely mentally Ills
- Antipsychotic drug treatments: Evoling treatment statergies
- Antipsychotic drug treatments: The use of polypharmacy to get improved outcomes
- BDNF pharmacogenetics of methamphetamine abuse
- Bipolar depression: diagnostic and management issues
- Bipolar disorder and its mangement: overview
- Bipolar Disorder: Journey from Pole to Pole Atypical Antipsychotic in the Management of Mood Disorder
- Boundaries of bipolar disorders and adequacy of treatment
- Candidate genes for response to risperidone: from mouse to man
- Clinical trials for cognitive deficits in schizophrenia: Boom or Bust?
- Cognitive function in euthymic state of bipolar disorders: association of brain serotonin transporter and brain derived neurotrophic factor
- Deinstitutionalization in Malaysia: a Myth or Reality?
- Do women benefit more from antipsychotics than men?
- From dementia praecox to schizophrenia - cognitive deficits and functional outcome in schizophrenia
- Glutamatergic pharmacogenetics of methamphetamine abuse and psychosis
- Harm reduction in custodial settings in Malaysia
- Harm reduction: An update and pharmacological aspects
- Histamine H3 receptor antagonists in preclinical models of cognition
- History of drug use and epidemiological aspects of drug use in Malaysia
- Home care in Malaysia: does it improve patients' care
- Hormone modulation: A novel approach to managing mental illness in women?
- Influence and interaction of genetic polymorphisms in the monoaminergic system and life stress on antidepressant drug response
- Modelling cognitive deficit symptoms in schizophrenia: Emerging Targets
- Near-infrared spectroscopy as a possible biomarker for predicting effect of methylphenidate in children with ADHD
- Neurochemical changes in the CNS of people with bipolar disorders
- Neuronal mechanisms of methamphetamine-seeking behaviour
- Neuropeptide S system in arousal, anxiety and panic disorder
- Novel biomarkers for schizophrenia in Malaysian population
- Optimizing treatment outcomes in patients with schizophrenia
- Orexin/dynorphin systems in control of motivated/reward behaviour
- Perhipheral biomarkers for psychosis
- Pharmacogenetics of symptom response to antipsychotic treatment
- Relaxin-3/RXFP3 networks - a newly identified ascending arousal system
- Separating schizophernia - what do microarrays of the CNS tell us?
- Social stress and defeat, from circuits to methylation - exploring stress-induced alterations in neurobiology that drive changes in behavioural state and cognitive function in the adult rat
- Special issues for women with bipolar affective disorder
- Spiritual enhancement drug addiction rehabilitation (SEDAR) An innovative platform for up scaling harm reduction in Malaysia
- Structural renal changes under long-term treatment with lithium - a 3T MR study
- The effects of methamphetamine on glutamatergic systems
- The effects of pharmacotherapy on brain in patients with OCD
- The national register of antipsychotic medication in pregnancy (NRAMP), The first 100 women.
- The neuropsychopharmacology of antidepressants and potential new mechanisms of action
- The role of animal models in understanding depression
- The role of cognitive remediation therapy (CRT) in psychosocial rehabilitation
- The role of inflammatory-related pathways in the pathophysiology of major depressive disorders and bipolar disorders
- The search for biomarkers in psychiatric disorders: Studies of the human CNS proteome
- Treating depression - Current best practice
47 abstracts